Dexrazoxane

FDA Approved: * September 28, 2004
Pharm Company: * BEDFORD
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Dexrazoxane Overview

Dexrazoxane hydrochloride (Zinecard, Cardioxane) is a cardioprotective agent. It was discovered by Eugene Herman in 1972. The IV administration of dexrazoxane is in acidic condition with HCl adjusting the pH.[1] Uses Dexrazoxane has been used to protect the heart against the cardiotoxic side effects of chemotherapeutic drugs such as anthracyclines,[2] such as daunorubicin or doxorubicin or other chemotherapeutic agents.[3] However, in July 20...

Read more Dexrazoxane Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dexrazoxane

Recent Dexrazoxane Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dexrazoxane
  • Injection: 250mg, 250mg/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Dexrazoxane: (11 results)

Sorted by National Drug Code
  • 0143-9247 Dexrazoxane 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 0143-9248 Dexrazoxane 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 42605-029 Dexrazoxane 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Thymoorgan Gmbh Pharmazir & Co. K.g
  • 42605-030 Dexrazoxane 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Thymoorgan Gmbh Pharmazir & Co. K.g
  • 47781-578 Dexrazoxane 500 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution by Alvogen Inc.
  • 51991-942 Dexrazoxane 500 mg/50ml Intravenous Injection, Solution by Breckenridge Pharmaceutical, Inc.
  • 67457-207 Dexrazoxane Hydrochloride Kit by Mylan Institutional LLC
  • 67457-208 Dexrazoxane Hydrochloride Kit by Mylan Institutional LLC
  • 68083-195 Dexrazoxane 500 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution by Gland Pharma Limited
  • 72266-101 Dexrazoxane 500 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution by Fosun Pharma USA Inc.
  • 76310-002 Cardioxane 500 mg Intravenous Injection, Powder, for Solution by Clinigen Healthcare Ltd

Other drugs which contain Dexrazoxane or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA